login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
EMERGENT BIOSOLUTIONS INC (EBS) Stock News
USA
- NYSE:EBS -
US29089Q1058
-
Common Stock
9.4
USD
-0.07 (-0.74%)
Last: 10/29/2025, 5:59:22 PM
10.76
USD
+1.36 (+14.47%)
After Hours:
10/29/2025, 5:59:22 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
EBS Latest News, Press Relases and Analysis
All
Press Releases
16 minutes ago - By: Chartmill
- Mentions:
FMC
WOLF
CMG
SFM
...
What's going on in today's after hours session
an hour ago - By: Benzinga
- Mentions:
ALGN
GH
GKOS
NTLA
...
12 Health Care Stocks Moving In Wednesday's After-Market Session
2 hours ago - By: Emergent BioSolutions
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
2 hours ago - By: Emergent BioSolutions
Emergent BioSolutions Reports Third Quarter 2025 Financial Results
11 hours ago - By: Benzinga
- Mentions:
CGO
ROL
ESRT
NNBR
...
Earnings Scheduled For October 29, 2025
a day ago - By: Emergent BioSolutions
Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness
21 days ago - By: Emergent BioSolutions
Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025
21 days ago - By: Emergent BioSolutions
Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025
a month ago - By: Emergent BioSolutions
Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone
a month ago - By: Emergent BioSolutions
Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone
a month ago - By: Stocktwits
- Mentions:
IWMW
AVSU
Emergent BioSolutions Stock Rises After Receiving Fresh International Purchase Orders: Retail Says Stock Is ‘Significantly Undervalued’
a month ago - By: Emergent BioSolutions
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner
a month ago - By: Emergent BioSolutions
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner
a month ago - By: Emergent BioSolutions
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain
a month ago - By: Emergent BioSolutions
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain
2 months ago - By: Emergent BioSolutions
Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness
2 months ago - By: Emergent BioSolutions
Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness
2 months ago - By: Emergent BioSolutions
Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
2 months ago - By: Emergent BioSolutions
Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
2 months ago - By: Emergent BioSolutions
Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day
2 months ago - By: Emergent BioSolutions
Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day
2 months ago - By: Emergent BioSolutions
Emergent BioSolutions to Participate in Upcoming Investor Conferences
2 months ago - By: Emergent BioSolutions
Emergent BioSolutions to Participate in Upcoming Investor Conferences
2 months ago - By: Emergent BioSolutions
Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™
2 months ago - By: Emergent BioSolutions
Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™
3 months ago - By: Emergent BioSolutions
Emergent BioSolutions Reports Second Quarter 2025 Financial Results
3 months ago - By: Emergent BioSolutions
Emergent BioSolutions Reports Second Quarter 2025 Financial Results
3 months ago - By: Yahoo Finance
- Mentions:
NOW
ServiceNow (NOW) Downgraded Due to Limited Upside Potential
3 months ago - By: Yahoo Finance
- Mentions:
AMD
GEV
Analysts Turn Bullish on AMD — Here’s What’s Powering the Optimism
3 months ago - By: Emergent BioSolutions
New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox
3 months ago - By: Emergent BioSolutions
Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives
Please enable JavaScript to continue using this application.